Skip to main content

Genetic Behind Psychiatric Disorders

Study reveals hidden genetic mechanisms behind psychiatric disorders



In a comprehensive review of recent genetic studies, researchers have identified a hidden layer of complexity in how our genes function, shedding new light on the biological underpinnings of major psychiatric disorders. The study published in Genomic Psychiatry reveals that a process called alternative polyadenylation (APA)—which affects how genes are expressed—may be a crucial factor in determining an individual's risk for conditions like schizophrenia, bipolar disorder, and depression. This discovery opens up exciting new avenues for understanding and potentially treating these complex mental health conditions.

"For years, we've known that psychiatric disorders have a strong genetic component, but pinpointing exactly how genes contribute to disease risk has been challenging," said Dr. Michelle Paff, lead author of the study. "Our research shows that it's not just about which genes you have, but also how those genes are processed and regulated."

The study focuses on APA, a mechanism that affects the stability and localization of messenger RNA (mRNA) molecules, which serve as blueprints for protein production in cells. By altering the length of a gene's 3' untranslated region (3'UTR), APA can significantly impact how much protein is produced from a given gene and where in the cell that protein ends up.

Using sophisticated computational techniques, the researchers analyzed data from multiple large-scale genetic studies, identifying 286 genes whose APA patterns were associated with psychiatric disorders. Remarkably, 60–65% of these genes had not previously been linked to these conditions through other genetic mechanisms.

"This finding suggests that APA may be a 'missing link' in our understanding of psychiatric genetics," explained Dr. Xiangmin Xu, senior author of the study. "It helps explain why some individuals with genetic risk factors develop disorders while others don't."

The study highlights several specific genes where APA appears to play a particularly important role:

DDHD2: Associated with schizophrenia risk, this gene's APA pattern may affect how neurons communicate.

FADS1: Linked to bipolar disorder, changes in this gene's APA could influence the metabolism of fatty acids crucial for brain function.

GABRA2: Also associated with bipolar disorder, APA of this gene may alter the balance of inhibitory signaling in the brain.

MTCH2: Connected to depression risk, APA of this gene could impact mitochondrial function and energy production in brain cells.

The researchers also found that genes affected by APA in psychiatric disorders tend to be involved in intracellular transport and cellular localization pathways. This suggests that APA may influence how proteins are moved and positioned within neurons, potentially disrupting normal brain function.

"These findings have significant implications for how we approach both research and treatment of psychiatric disorders," said Dr. Paff. "By understanding the role of APA, we may be able to develop more targeted therapies that address the root causes of these conditions at a molecular level."

The study's authors caution that more research is needed to fully understand the implications of these findings. However, they are optimistic about the potential for this work to lead to new diagnostic tools and treatment strategies.

"This line of work opens up a whole new dimension in psychiatric genetics," Dr. Xu concluded. "It's an exciting time in the field, and we believe this work will accelerate our progress towards better outcomes for individuals living with these challenging conditions."

psychiatric disorders, genetic mechanisms, schizophrenia, bipolar disorder, depression, autism spectrum disorder, genome-wide association studies, GWAS, whole-exome sequencing, genetic variants, neurodevelopment, synaptic function, neurotransmitter regulation, immune system, mental health, precision medicine, personalized treatments, diagnostic tools, early intervention, neuroscience, genetic research,

#PsychiatricDisorders, #GeneticMechanisms, #Schizophrenia, #BipolarDisorder, #Depression, #AutismSpectrumDisorder, #GWAS, #WholeExomeSequencing, #GeneticVariants, #Neurodevelopment, #SynapticFunction, #NeurotransmitterRegulation, #ImmuneSystem, #MentalHealth, #PrecisionMedicine, #PersonalizedTreatments, #EarlyIntervention, #Neuroscience, #GeneticResearch, #MentalHealthResearch

International Conference on Genetics and Genomics of Diseases 




For Enquiries: genetics@healthcarek.com 

Get Connected Here 
--------------------------------- 
--------------------------------- 
facebook.com/profile.php?id=61555903296992 
tumblr.com/blog/dorita0211 

Comments

Post a Comment

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...
Post a Comment
Read more

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...
Post a Comment
Read more

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...
Post a Comment
Read more